Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve Immunogenicity of Myeloma Tumor Antigen to Enhance Th1 Polarization of Dendritic Cells

My-Dung Hoang, Hwa-Jeong Lee, Hyun-Ju Lee, Sung-Hoon Jung, Nu-Ri Choi, Manh-Cuong Vo, Thanh-Nhan Nguyen-Pham, In-Kyu Park, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD

Blood (2014) 124 (21): 5763.

https://doi.org/10.1182/blood.V124.21.5763.5763

Published: 2014

Journal Articles

Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study To Evaluate The Safety and Tolerability Of Intravenous Infusion Of SNS01-T In Patients With Relapsed Or Refractory Multiple Myeloma, Mantle Cell Lymphoma, Or Diffuse Large B Cell Lymphoma

John A Lust, Charles Barranco, Saad Z Usmani, MD FACP, Frits van Rhee, MD, PhD, Mehdi Hamadani, MD, John Thompson, Catherine A Taylor, Richard Dondero, Leslie J. Browne, PhD, David Siegel, William I. Bensinger, MD

Blood (2013) 122 (21): 1950.

https://doi.org/10.1182/blood.V122.21.1950.1950

Published: 2013

Journal Articles

SNS01-T Exhibits Significant Anti-Tumoral Activity In Models Of Multiple Myeloma and Non-Hodgkins B Cell Lymphoma and Induces Cell Death In Malignant But Not Normal B Cells

Catherine A Taylor, Terence Tang, Sarah Francis, Zhongda Liu, Qifa Zheng, Richard Dondero, John Thompson

Blood (2013) 122 (21): 880.

https://doi.org/10.1182/blood.V122.21.880.880

Published: 2013

Journal Articles

Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma.

John A Lust, MD, PhD, Saad Z Usmani, MD FACP, Mehdi Hamadani, MD, Charles Barranco, Martha Q Lacy, MD, Angela Dispenzieri, MD, Morie A Gertz, David Dingli, M.D., Ph.D., Stephen Russell, MD, PhD, Francis K Buadi, M.D., Steven R Zeldenrust, MD, PhD, Suzanne R Hayman, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD, John Thompson, Catherine A Taylor, Richard Dondero

Blood (2012) 120 (21): 2973.

https://doi.org/10.1182/blood.V120.21.2973.2973

Published: 2012

Journal Articles

Polyethylene Glycol - Polyethylenimine Nanoparticle-Mediated Transfection of Mir-150 Into the Leukemia Cells and Determination of the Expression Pattern Changes in Apoptosis and Cell Cycle Genes

Tugce Balci, Cigir Biray Avci, Ipek Ozcan, Sunde Yilmaz Susluer, Cagla Kayabasi, Guray Saydam, MD, Cumhur Gunduz

Blood (2012) 120 (21): 4679.

https://doi.org/10.1182/blood.V120.21.4679.4679

Published: 2012

Journal Articles

Targeted Delivery of MicroRNA-29b by Nanoparticles Provides Antileukemic Activity and Increases Sensitivity to the Hypomethylating Agent Decitabine (DAC) in Acute Myeloid Leukemia (AML)

Xiaomeng Huang, Sebastian Schwind, MD, Bo Yu, Ph.D, Jiuxia Pang, Ramasamy Santhanam, Ph.D, Kenneth K. Chan, Ph.D, Ramiro Garzon, MD, William Blum, MD, Clara D. Bloomfield, MD, Shujun Liu, Ph.D, Danilo Perrotti, MD, Ph.D, Robert J. Lee, Ph.D, John C. Byrd, MD, Natarajan Muthusamy, DVM, Ph.D, L. James Lee, Ph.D, Guido Marcucci, MD

Blood (2011) 118 (21): 81.

https://doi.org/10.1182/blood.V118.21.81.81

Published: 2011

Journal Articles

Systemic Delivery of the Cancer Gene Therapy Biologic, SNS01, Has Significant Anti-Tumoral Activity in a Murine Model of Multiple Myeloma.

Catherine A Taylor, John A. Lust, MD, PhD, Bin Ye, Zhongda Liu, Zhong Sun, Richard S. Dondero, PhD, Bruce Galton, Kathleen A. Donovan, Ph.D., John E. Thompson

Blood (2009) 114 (22): 2462.

https://doi.org/10.1182/blood.V114.22.2462.2462

Published: 2009

Journal Articles

Preclinical Studies Using Polyethylenimine (PEI) Nanoparticles Complexed with Eukaryotic Translation Initiation Factor 5A (eIF5A) siRNA and eIF5A K50R Plasmid DNA Demonstrates Significant Anti-Myeloma Activity in Vitro and in Vivo

John A. Lust, MD, PhD, John E. Thompson, PhD, Catherine A. Taylor, PhD, Bin Ye, Zhongda Liu, Zhong Sun, Richard S. Dondero, PhD, Laurie L. Moon-Tasson, Michael P. Kline, PhD, Kathleen A. Donovan, PhD

Blood (2008) 112 (11): 249.

https://doi.org/10.1182/blood.V112.11.249.249

Published: 2008

Journal Articles

Regulation of Platelet Functions by Targeting STAT3 with a g-Quartet Oligonucleotide.

Zhou Zhou, MD, Yongli Guan, Wensheng Sun, Naijie Jin, PhD, Jing-fei Dong, MD PhD

Blood (2007) 110 (11): 3640.

https://doi.org/10.1182/blood.V110.11.3640.3640

Published: 2007

Journal Articles

Gene Transfer to Macrophages with Nanoparticle-Loaded Platelets.

Christopher M. Scull, Ruben Kuruvilla, Thomas H. Fischer, PhD, Timothy C. Nichols, MD

Blood (2005) 106 (11): 3043.

https://doi.org/10.1182/blood.V106.11.3043.3043

Published: 2005

Journal Articles

Efficient Transduction of Common Marmoset (Callithrix jacchus) Hematopoietic and Embryonic Stem Cells Using Foamyvirus Vectors.

Peter A. Horn, MD, Melanie Wurm, Ryo Kurita, PhD, Tomoko Yokoo, Rainer Blasczyk, MD, Dirk Lindemann, PhD, Helmut Hanenberg, MD, Kenzaburo Tani, MD, PhD

Blood (2005) 106 (11): 5530.

https://doi.org/10.1182/blood.V106.11.5530.5530

Published: 2005

NARROW

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve Immunogenicity of Myeloma Tumor Antigen to Enhance Th1 Polarization of Dendritic Cells

Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study To Evaluate The Safety and Tolerability Of Intravenous Infusion Of SNS01-T In Patients With Relapsed Or Refractory Multiple Myeloma, Mantle Cell Lymphoma, Or Diffuse Large B Cell Lymphoma

SNS01-T Exhibits Significant Anti-Tumoral Activity In Models Of Multiple Myeloma and Non-Hodgkins B Cell Lymphoma and Induces Cell Death In Malignant But Not Normal B Cells

Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma.

Polyethylene Glycol - Polyethylenimine Nanoparticle-Mediated Transfection of Mir-150 Into the Leukemia Cells and Determination of the Expression Pattern Changes in Apoptosis and Cell Cycle Genes

Targeted Delivery of MicroRNA-29b by Nanoparticles Provides Antileukemic Activity and Increases Sensitivity to the Hypomethylating Agent Decitabine (DAC) in Acute Myeloid Leukemia (AML)

Systemic Delivery of the Cancer Gene Therapy Biologic, SNS01, Has Significant Anti-Tumoral Activity in a Murine Model of Multiple Myeloma.

Preclinical Studies Using Polyethylenimine (PEI) Nanoparticles Complexed with Eukaryotic Translation Initiation Factor 5A (eIF5A) siRNA and eIF5A K50R Plasmid DNA Demonstrates Significant Anti-Myeloma Activity in Vitro and in Vivo

Regulation of Platelet Functions by Targeting STAT3 with a g-Quartet Oligonucleotide.

Gene Transfer to Macrophages with Nanoparticle-Loaded Platelets.

Efficient Transduction of Common Marmoset (Callithrix jacchus) Hematopoietic and Embryonic Stem Cells Using Foamyvirus Vectors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only